Next Article in Journal
Competing Endogenous RNAs, Non-Coding RNAs and Diseases: An Intertwined Story
Next Article in Special Issue
Small-Molecule Chemical Knockdown of MuRF1 in Melanoma Bearing Mice Attenuates Tumor Cachexia Associated Myopathy
Previous Article in Journal
Cetuximab and IL-15 Promote NK and Dendritic Cell Activation In Vitro in Triple Negative Breast Cancer
Article

NeuroHeal Reduces Muscle Atrophy and Modulates Associated Autophagy

1
Institut de Neurociències (INc) and Department of Cell Biology, Physiology and Immunology, Universitat Autònoma de Barcelona (UAB), Bellaterra, 08193 Barcelona, Spain
2
Pulmonology Department-Muscle Wasting and Cachexia in Chronic Respiratory Diseases and Lung Cancer Research Group, IMIM-Hospital del Mar, Parc de Salut Mar, Health and Experimental Sciences Department (CEXS), Universitat Pompeu Fabra (UPF), Barcelona Biomedical Research Park (PRBB), 08003 Barcelona, Spain
3
Centro de Investigación en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III (ISCIII), 08003 Barcelona, Spain
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Current address: Institut Necker Enfants-Malades (INEM), INSERM U1151, Laboratory “Hormonal regulation of brain development and functions”—Team 8, Université Paris Descartes, Sorbonne Paris Cité, 75015 Paris, France.
Cells 2020, 9(7), 1575; https://doi.org/10.3390/cells9071575
Received: 15 May 2020 / Revised: 23 June 2020 / Accepted: 24 June 2020 / Published: 28 June 2020
(This article belongs to the Special Issue Skeletal Muscle Atrophy: Mechanisms at a Cellular Level)
Muscle wasting is an unmet medical need which leads to a reduction of myofiber diameter and a negative impact on the functional performance of daily activities. We previously found that a new neuroprotective drug called NeuroHeal reduced muscle atrophy produced by transient denervation. Aiming to decipher whether NeuroHeal has a direct role in muscle biology, we used herein different models of muscle atrophy: one caused by chronic denervation, another caused by hindlimb immobilization, and lastly, an in vitro model of myotube atrophy with Tumor Necrosis Factor-α (TNFα). In all these models, we observed that NeuroHeal reduced muscle atrophy and that SIRT1 activation seems to be required for that. The treatment downregulated some critical markers of protein degradation: Muscle Ring Finger 1 (MuRF1), K48 poly-Ub chains, and p62/SQSTM1. Moreover, it seems to restore the autophagy flux associated with denervation. Hence, we envisage a prospective use of NeuroHeal at clinics for different myopathies. View Full-Text
Keywords: NeuroHeal; skeletal muscle atrophy; sirtuin 1; autophagy; proteasome NeuroHeal; skeletal muscle atrophy; sirtuin 1; autophagy; proteasome
Show Figures

Figure 1

MDPI and ACS Style

Marmolejo-Martínez-Artesero, S.; Romeo-Guitart, D.; Mañas-García, L.; Barreiro, E.; Casas, C. NeuroHeal Reduces Muscle Atrophy and Modulates Associated Autophagy. Cells 2020, 9, 1575. https://doi.org/10.3390/cells9071575

AMA Style

Marmolejo-Martínez-Artesero S, Romeo-Guitart D, Mañas-García L, Barreiro E, Casas C. NeuroHeal Reduces Muscle Atrophy and Modulates Associated Autophagy. Cells. 2020; 9(7):1575. https://doi.org/10.3390/cells9071575

Chicago/Turabian Style

Marmolejo-Martínez-Artesero, Sara, David Romeo-Guitart, Laura Mañas-García, Esther Barreiro, and Caty Casas. 2020. "NeuroHeal Reduces Muscle Atrophy and Modulates Associated Autophagy" Cells 9, no. 7: 1575. https://doi.org/10.3390/cells9071575

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop